EspeRare awarded a Grand Challenges Grant from the Gates Foundation
Every year, preeclampsia endangers millions of mothers and babies worldwide.
At Esperare, we believe care should begin before birth.
With this goal in mind, we have been awarded a Grand Challenges grant to explore a new therapeutic approach for preeclampsia, one of the leading causes of maternal and neonatal mortality globally. This support strengthens our commitment to maternal and fetal health and helps us advance early-life innovations toward careful clinical evaluation for the families who need them most.
“We are grateful to the Gates Foundation for its support in shaping a future where care begins before birth” said our Executive Director Caroline Kant. “It also underscores that a purpose-driven drug-development model like ours can help unlock responsible options for long-overlooked conditions such as preeclampsia.”
Read more about the project on the Global Grand Challenges website